Securities Code: 301602 Securities Abbreviation: Chaoyan Shares Announcement No.: 2026-016 Shantou Ultrasound Instruments Research Institute Co., Ltd. Special Report on the Storage, Management, and Actual Use of Raised Funds for 2025
The Company and all members of the Board of Directors guarantee the truthfulness, accuracy, and completeness of the information disclosed, and are free from any false records, misleading statements, or material omissions.
I. Basic情况 of Raised Funds (I) Amount of Funds Actually Raised and Time of Arrival Upon approval of the "Reply on the Registration of the Initial Public Offering of Shares of Shantou Ultrasound Instruments Research Institute Co., Ltd." (Zhengjian Permit (2024) No. 1391) by the China Securities Regulatory Commission, Shantou Ultrasound Instruments Research Institute Co., Ltd. (hereinafter referred to as the "Company") has completed its initial public offering of RMB ordinary shares (A shares) of 64,249,446 shares at an issuance price of RMB 6.70 per share. The total raised funds amounted to RMB 430,471,288.20. After deducting issuance expenses of RMB 46,108,086.88 (excluding tax), the net amount of raised funds was RMB 384,363,201.32. The raised funds were transferred to the Company's designated account on January 17, 2025. Huaxing Certified Public Accountants (Special General Partnership) audited the arrival of funds for the Company's initial public offering and issued an "Audit Report" (Huaxing Audit Word [2025] No. 21001371272) on January 17, 2025. After the raised funds arrived, the Company stored them in a special account.
(II) Situation of Raised Funds Use and Balance as of December 31, 2025 Funds invested in this period amounted to RMB 126,557,270.69, with a cumulative investment of RMB 126,557,270.69. The balance of raised funds as of December 31, 2025, was RMB 26,732,335.14. The specific situation is as follows:
| Item | Amount (RMB) |
|---|---|
| Total Raised Funds | 430,471,288.20 |
| Less: Issuance Expenses | 46,108,086.88 |
| Net Raised Funds | 384,363,201.32 |
| Add: Un-offset Issuance Expenses | 377,382.77 |
| Less: Purchase of Structured Deposits and Time Deposits | 234,000,000.00 |
| Cumulative Raised Funds Used by End of Period | 126,557,270.69 |
| Of which: Directly Invested in Raised Fund Projects | 13,312,360.20 |
| Offset of Self-raised Funds Pre-invested in Raised Fund Projects | 113,244,910.49 |
| Add: Net Interest Income After Handling Fees | 2,549,021.74 |
| Balance of Raised Fund Special Accounts as of December 31, 2025 | 26,732,335.14 |
II. Storage and Management of Raised Funds
- Management of Raised Funds To standardize the use and management of the Company's raised funds, improve the efficiency of raised fund utilization, and ensure the safety of fund use and protect investors' interests, in accordance with the "Company Law of the People's Republic of China," "Securities Law of the People's Republic of China," "Supervision Rules for Listed Company Raised Funds," "Shenzhen Stock Exchange SME Board Stock Listing Rules (2025 Revision)," and other relevant regulations, and in combination with the Company's actual situation, the Company has formulated the "Management System for Raised Funds of Shantou Ultrasound Instruments Research Institute Co., Ltd." (hereinafter referred to as the "Raised Funds Management System").